发明名称 |
ANTI-KDR ANTIBODIES AND METHODS OF USE |
摘要 |
The present invention provides anti-KDR monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of a variety of cancers, rheumatoid arthritis, diabetic retinopathy and other diseases associated with aberrant VEGF or KDR expression and/or activity. |
申请公布号 |
US2014377282(A1) |
申请公布日期 |
2014.12.25 |
申请号 |
US201214356120 |
申请日期 |
2012.11.01 |
申请人 |
Ke Yaohuang;Lee Sum Wai Pierre;Zhang Yongke;Yu Guo-Liang;Zhu Weimin |
发明人 |
Ke Yaohuang;Lee Sum Wai Pierre;Zhang Yongke;Yu Guo-Liang;Zhu Weimin |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated antibody, or an antigen-binding fragment thereof, that binds to KDR, comprising (i) a heavy chain variable region comprising the VHCDR1 region set forth in SEQ ID NO:3 or 11, the VHCDR2 region set forth in SEQ ID NO:4 or 12, and the VHCDR3 region set forth SEQ ID NO:5; and (ii) a light chain variable region comprising the VLCDR1 region set forth in SEQ ID NO:6, the VLCDR2 region set forth in SEQ ID NO:7, and the VLCDR3 region set forth in SEQ ID NO: 8;
or a variant of said antibody, or an antigen-binding fragment thereof, comprising heavy and light chain variable regions identical to the heavy and light chain variable regions of (i) and (ii) except for up to 8 amino acid substitutions in said CDR regions. |
地址 |
San Francisco CA US |